On January 23, 2024, DaShenLin Pharmaceutical Group Co., Ltd. cancelled the transaction. The transaction has been approved by Shangai Stock exchange.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.12 CNY | -3.24% | +1.56% | -11.16% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.16% | 3.49B | |
-34.16% | 14.83B | |
-24.55% | 12.04B | |
+14.96% | 6.44B | |
-25.24% | 6.52B | |
-8.01% | 6.15B | |
-2.34% | 4.64B | |
+60.00% | 4.62B | |
-8.10% | 3.93B | |
-6.77% | 3.05B |
- Stock Market
- Equities
- 603233 Stock
- News DaShenLin Pharmaceutical Group Co., Ltd.
- DaShenLin Pharmaceutical Group Co., Ltd. cancelled the transaction announced on January 19, 2023